INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Regeneron Pharmaceuticals, Inc. - REGN
Portfolio Pulse from
Pomerantz Law Firm has filed a class action lawsuit against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Investors are advised to contact the firm for more information.
March 03, 2025 | 6:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. by Pomerantz Law Firm. This legal action could impact investor sentiment and the company's stock price.
The filing of a class action lawsuit against Regeneron Pharmaceuticals is likely to negatively impact the stock price in the short term due to potential legal liabilities and negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100